Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

5.21
+0.44009.22%
Post-market: 5.290.0781+1.50%19:59 EDT
Volume:18.07M
Turnover:94.18M
Market Cap:1.03B
PE:6.60
High:5.45
Open:5.20
Low:5.09
Close:4.77
52wk High:5.45
52wk Low:3.49
Shares:196.94M
Float Shares:123.00M
Volume Ratio:10.07
T/O Rate:14.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7896
EPS(LYR):-0.1748
ROE:89.58%
ROA:48.84%
PB:3.97
PE(LYR):-29.80

Loading ...

Arbutus Biopharma Shares Rise on $230 Million Stock Buyback

Dow Jones
·
Aug 21

Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday

MT Newswires Live
·
Aug 21

U.S. Stocks on the MOVE-Ubiquiti, BJ's Wholesale, Arbutus

Reuters
·
Aug 21

Arbutus Biopharma Announces Major Share Repurchase Tender Offer

TIPRANKS
·
Aug 21

Arbutus Climbs After Unveiling Buyback from Moderna Settlement Proceeds

Reuters
·
Aug 21

Arbutus Biopharma to repurchase $230M of shares through Dutch Auction

TIPRANKS
·
Aug 21

Arbutus Plans Modified Dutch Auction Tender Offer to Repurchase up to Us$230 Million Shares at US$5-5.75 Each

Reuters
·
Aug 21

Arbutus Biopharma Corp: Offer Purchase Price of not Less than Us$5.00 Per Share and not More than Us$5.75 Per Share, in Cash

THOMSON REUTERS
·
Aug 21

Arbutus Biopharma Corp: Offer is Expected to be Funded Through Company's Cash on Hand

THOMSON REUTERS
·
Aug 21

Arbutus Announces Intent to Repurchase up to Us$230 Million of Its Common Shares Through Modified “Dutch Auction” Tender Offer

THOMSON REUTERS
·
Aug 21

Arbutus Biopharma Corp: Offer is Expected to Commence on or About August 24, 2026 And, Unless Extended or Terminated by Co

THOMSON REUTERS
·
Aug 21

ProQR Q2 Revenue More than Doubles

Reuters
·
Aug 13

Atea Pharmaceuticals Q2 Loss Narrows as HCV Trial Expenses Decline

Reuters
·
Aug 13

Arbutus Q2 FY26 Net Loss Widens to $5.1 Million; Revenue Drops 90.56% to $1.01 Million

Reuters
·
Aug 12

Arbutus Biopharma Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.014M Beat $700.000K Estimate

Benzinga Earnings
·
Aug 12

Earnings Flash (ABUS) Arbutus Biopharma Posts Q2 Loss $0.03 a Share, vs. FactSet Est of $0.02 Loss

MT Newswires Live
·
Aug 12

Arbutus Biopharma Q2 Revenue USD 1 Million

THOMSON REUTERS
·
Aug 12

Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 12

Arbutus Biopharma Corp Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Reuters
·
Jul 31

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

TIPRANKS
·
Jul 17